ArticleHead & neck2026

Treatment-Related Adverse Events and Health-Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review.

N D O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.